Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ocular Therapeutix

Explore full profile

Biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye

Bedford, United StatesFounded 2006Biotech & Life Sciences
Valuation $1.20B Market cap · Aug/2026
Revenue $52M Latest reported FY

At a glance

Founded
2006
Headquarters
Bedford, United States
Listing
IPO 2014
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierColt$25–100M revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later15 investors entered at this stage

  • Great Point Partners
  • Acuta Capital Partners
  • Versant Ventures
  • Ascension Ventures
  • SV Health Investors
  • Opaleye Management
  • Deep Track Capital
  • Baxter International
  • Ascension
  • TCGX
  • Logos Capital
  • Polaris Partners
  • Surveyor Capital
  • Venrock Healthcare Capital Partners
  • Perceptive Advisors

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Ocular Therapeutix employees who went on to found companies, sorted by Dealroom signal score.

OstialEst. 2009
Fred KhosraviUnited States
Signal score76
hC BioscienceEst. 2021
Leslie WilliamsUnited States
Signal score61
Pandion TherapeuticsEst. 2016
ACAlan CraneUnited States
Signal score58
SincerelyEst. 2011
Brian KennedyUnited States
Signal score54
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Bedford HQ
Book a demo for the full country breakdown
Web traffic by country
11K monthly visits
across markets
🇺🇸 United States70.9%
🇮🇳 India15.5%
🇧🇪 Belgium8.2%
🇨🇦 Canada6.4%
🇩🇪 Germany1.8%
Top 5 markets shown

Patents

Estimated portfolio value
$31M

34 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ocular Therapeutix on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ocular Therapeutix on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles